These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3222467)

  • 1. Differences in radiation response among human cervix carcinoma cell lines.
    Kelland LR; Steel GG
    Radiother Oncol; 1988 Nov; 13(3):225-32. PubMed ID: 3222467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery from radiation damage in human squamous carcinoma of the cervix.
    Kelland LR; Steel GG
    Int J Radiat Biol; 1989 Jan; 55(1):119-27. PubMed ID: 2562968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intrinsic radiosensitivity and sublethal damage repair capacity of five cervical carcinoma cell lines tested with the 96-well-plate assay.
    Rantanen V; Grénman S; Kulmala J; Grénman R
    J Cancer Res Clin Oncol; 1995; 121(4):230-4. PubMed ID: 7751322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation survival of two human cervical carcinoma cell lines after multifraction irradiation.
    Werts ED; Burholt DR; Paljug WR; Polizotto SL; Yann VM
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):941-50. PubMed ID: 8751403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the in vivo and in vitro radiation response of three human cervix carcinomas.
    Tonkin KS; Kelland LR; Steel GG
    Radiother Oncol; 1989 Sep; 16(1):55-63. PubMed ID: 2813837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential application of the ATP cell viability assay in the measurement of intrinsic radiosensitivity in cervical cancer.
    Tam KF; Ng TY; Liu SS; Tsang PC; Kwong PW; Ngan HY
    Gynecol Oncol; 2005 Mar; 96(3):765-70. PubMed ID: 15721424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-rate effects between 0.3 and 30 Gy/h in a normal and a malignant human cell line.
    Amdur RJ; Bedford JS
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):83-90. PubMed ID: 8083132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-rate effects in the radiation response of four human tumour xenografts.
    Kelland LR; Steel GG
    Radiother Oncol; 1986 Nov; 7(3):259-68. PubMed ID: 3809588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The dosage-performance effects on Ca-Ski and HPK cells in relation to the dose and fractionation].
    Schulz-Wendtland R; Krämer S; Keilholz L; Pflüger S; Lang N
    Strahlenther Onkol; 1996 Aug; 172(8):439-45. PubMed ID: 8765347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractionated irradiation of five human lung cancer cell lines and prediction of survival according to a radiobiology model.
    Hedman M; Bergqvist M; Brattström D; Brodin O
    Anticancer Res; 2011 Apr; 31(4):1125-30. PubMed ID: 21508355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between clonogenic cell survival, DNA damage and chromosomal radiosensitivity in nine human cervix carcinoma cell lines.
    Eastham AM; Atkinson J; West CM
    Int J Radiat Biol; 2001 Mar; 77(3):295-302. PubMed ID: 11258843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study.
    Eifel PJ; Moughan J; Owen J; Katz A; Mahon I; Hanks GE
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):351-8. PubMed ID: 10030261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness.
    Britten RA; Evans AJ; Allalunis-Turner MJ; Franko AJ; Pearcey RG
    Radiother Oncol; 1996 May; 39(2):145-53. PubMed ID: 8735482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of keratinocyte growth factor on the proliferation and radiation survival of human squamous cell carcinoma cell lines in vitro and in vivo.
    Ning S; Shui C; Khan WB; Benson W; Lacey DL; Knox SJ
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):177-87. PubMed ID: 9422575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dose-rate effect in human tumour cells.
    Steel GG; Deacon JM; Duchesne GM; Horwich A; Kelland LR; Peacock JH
    Radiother Oncol; 1987 Aug; 9(4):299-310. PubMed ID: 3317524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
    Ning S; Trisler K; Wessels BW; Knox SJ
    Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of a relationship between colony-forming efficiency and surviving fraction at 2 Gy.
    West CM; Davidson SE; Pool C; James RD; Schofield PF
    Radiat Res; 1991 May; 126(2):260-3. PubMed ID: 2023996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No benefits of ultrafractionation in two head-and-neck cancer cell lines with different inherent radiosensitivity.
    Boehringer-Wyss N; Clarkson SG; Allal AS
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1099-103. PubMed ID: 11958907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compensation for changes in dose-rate in radical low-dose-rate brachytherapy: a radiobiological analysis of a randomised clinical trial.
    Roberts SA; Hendry JH; Swindell R; Wilkinson JM; Hunter RD
    Radiother Oncol; 2004 Jan; 70(1):63-74. PubMed ID: 15036854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.